Switch theme
Sign up to access all valuation multiples
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
2014
5.5K+
LTM Revenue $1.9B
LTM EBITDA $416M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Curaleaf has a last 12-month revenue (LTM) of $1.9B and a last 12-month EBITDA of $416M.
In the most recent fiscal year, Curaleaf achieved revenue of $969M and an EBITDA of $168M.
Curaleaf expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Curaleaf valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | XXX | $969M | XXX | XXX | XXX |
| Gross Profit | $908M | XXX | $461M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $416M | XXX | $168M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 17% | XXX | XXX | XXX |
| EBIT | $45.1M | XXX | $14.6M | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | -$287M | XXX | -$155M | XXX | XXX | XXX |
| Net Margin | -15% | XXX | -16% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $343M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Curaleaf's stock price is CAD 1 (or $1).
Curaleaf has current market cap of CAD 863M (or $623M), and EV of CAD 1.9B (or $1.3B).
See Curaleaf trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $623M | XXX | XXX | XXX | XXX | $-0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Curaleaf has market cap of $623M and EV of $1.3B.
Curaleaf's trades at 1.4x EV/Revenue multiple, and 8.0x EV/EBITDA.
Equity research analysts estimate Curaleaf's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Curaleaf has a P/E ratio of -3.0x.
See valuation multiples for Curaleaf and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $623M | XXX | $623M | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | 8.0x | XXX | XXX | XXX |
| EV/EBIT | 41.4x | XXX | 92.5x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.0x | XXX | -4.0x | XXX | XXX | XXX |
| EV/FCF | 15.8x | XXX | 29.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCuraleaf's last 12 month revenue growth is -3%
Curaleaf's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Curaleaf's rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Curaleaf's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Curaleaf and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | -1% | XXX | 44% | XXX | XXX | XXX |
| Rule of 40 | 11% | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Curaleaf acquired XXX companies to date.
Last acquisition by Curaleaf was XXXXXXXX, XXXXX XXXXX XXXXXX . Curaleaf acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Curaleaf founded? | Curaleaf was founded in 2014. |
| Where is Curaleaf headquartered? | Curaleaf is headquartered in Canada. |
| How many employees does Curaleaf have? | As of today, Curaleaf has 5.5K+ employees. |
| Who is the CEO of Curaleaf? | Curaleaf's CEO is Mr. Boris Jordan. |
| Is Curaleaf publicy listed? | Yes, Curaleaf is a public company listed on TSE. |
| What is the stock symbol of Curaleaf? | Curaleaf trades under CURA ticker. |
| When did Curaleaf go public? | Curaleaf went public in 2015. |
| Who are competitors of Curaleaf? | Similar companies to Curaleaf include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of Curaleaf? | Curaleaf's current market cap is $623M |
| What is the current revenue of Curaleaf? | Curaleaf's last 12 months revenue is $1.9B. |
| What is the current revenue growth of Curaleaf? | Curaleaf revenue growth (NTM/LTM) is -3%. |
| What is the current EV/Revenue multiple of Curaleaf? | Current revenue multiple of Curaleaf is 1.0x. |
| Is Curaleaf profitable? | Yes, Curaleaf is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Curaleaf? | Curaleaf's last 12 months EBITDA is $416M. |
| What is Curaleaf's EBITDA margin? | Curaleaf's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Curaleaf? | Current EBITDA multiple of Curaleaf is 4.5x. |
| What is the current FCF of Curaleaf? | Curaleaf's last 12 months FCF is $119M. |
| What is Curaleaf's FCF margin? | Curaleaf's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Curaleaf? | Current FCF multiple of Curaleaf is 15.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
